Realtime News
Performance
29.11.2021

DGAP-News 29.11.21 22:05 DGAP-News: SV Werder Bremen GmbH & Co KG aA
SV Werder Bremen GmbH & Co KG aA: Der SV Werder Bremen GmbH & [...]
EQS-Ad-hoc 29.11.21 22:05 EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG
Relief Reports U.S. Collaboration Partner Identifies Significa[...]
DGAP-News 29.11.21 22:02 DGAP-News: MorphoSys AG
MorphoSys AG: Unternehmenskalender 2022
EQS-Reg 29.11.21 21:10 EQS-Reg: Ørsted A/S
Notification of managers’ transactions
DGAP-News 29.11.21 20:00 DGAP-News: Berenberg
Notification of performed Stabilisation Measures pursuant to A[...]
DGAP-Ad-hoc 29.11.21 19:50 DGAP-Ad-hoc: Northern Data AG
Northern Data AG: Staatsanwaltschaft Frankfurt a. M. stellt Vo[...]
DGAP-News 29.11.21 19:12 DGAP-News: BP p.l.c. (RNS)
BP p.l.c.: Transaction in Own Shares
EQS-News 29.11.21 19:05 EQS-News: SunMirror AG
SunMirror AG: SunMirror AG: Aktien ab 30.11.2021 an der Frankf[...]
DGAP-Kapitalmarktinformation 29.11.21 19:00 DGAP-Kapitalmarktinformation: CANCOM SE
CANCOM SE: Veröffentlichung einer Kapitalmarktinformation
DGAP-DD 29.11.21 18:08 DGAP-DD: Mister Spex SE
Kauf / Kretschmer, Birgit
DGAP-DD 29.11.21 18:01 DGAP-DD: FCR Immobilien AG
Kauf / CM Center Management GmbH
DGAP-DD 29.11.21 18:00 DGAP-DD: Mister Spex SE
Kauf / Kretschmer, Birgit
DGAP-DD 29.11.21 18:00 DGAP-DD: FCR Immobilien AG
Verkauf / Raudies, Falk
EQS-Ad-hoc 29.11.21 18:00 EQS-Ad-hoc: Sandpiper Digital Payments AG
SANDPIPER Digital Payments AG (BX Swiss, Symbol: SDPN, www.san[...]
EQS-News 29.11.21 17:54 EQS-News: IMMOFINANZ AG
IMMOFINANZ mit Top-Performance in Q1-3 2021: Operatives Ergebn[...]
DGAP-Stimmrechtsanteile 29.11.21 17:51 DGAP-Stimmrechtsanteile: Mister Spex SE
Mister Spex SE: Release according to Article 40, Section 1 of [...]
DGAP-News 29.11.21 17:50 DGAP-News: EQS Group AG
EQS Group AG: Erwerb eigener Aktien abgeschlossen
DGAP-Kapitalmarktinformation 29.11.21 17:47 DGAP-Kapitalmarktinformation: Scout24 SE
Korrektur der Veröffentlichung vom 29.11.2021, 16:49 Uhr CET/C[...]
DGAP-Stimmrechtsanteile 29.11.21 17:46 DGAP-Stimmrechtsanteile: Diebold Nixdorf, In[...]
Diebold Nixdorf, Incorporated: Release according to Article 40[...]
EQS-Ad-hoc 29.11.21 17:41 EQS-Ad-hoc: Burkhalter Holding AG
Burkhalter Gruppe kauft Elektrotechnik-Unternehmen im Wallis

Indizes

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.

29. November 2021